Want to see IN:QUICKHEAL full AI Analyst Report?
Quick Heal Technologies Ltd. (QUICKHEAL) AI Stock Analysis
Quick Heal Technologies Ltd.
(NSE:QUICKHEAL)
Quick Heal Technologies receives a low overall score primarily driven by deteriorating core business fundamentals, including significant operational losses yielding a negative P/E ratio. While the company possesses an exceptionally strong, debt-free balance sheet and shows signs of short-term price recovery, the lack of consistent cash flow and a longer-term bearish technical setup weigh heavily on its evaluation.
Quick Heal Technologies Ltd. (QUICKHEAL) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 8.38B
- Dividend Yield
- ―
- Average Volume (3M)
- 21.20K
- Price to Earnings (P/E)
- -83.9
- Beta (1Y)
- 2.11
- Revenue Growth
- -6.64%
- EPS Growth
- -137.20%
- Country
- India
- Employees
- 884
- Sector
- General
- Sector Strength
- 55
- Industry
- Software - Application
Quick Heal Technologies Ltd. Business Overview & Revenue Model
Company Description
Quick Heal Technologies Limited, an Indian company established in Pune in 1995, specializes in providing cybersecurity software and solutions. The firm caters to a diverse clientele, including individual consumers, small and medium-sized businesses,...
Quick Heal Technologies Ltd. Financial Statement Overview
Summary
Maintains a fortress-like balance sheet with virtually zero debt, but this is heavily offset by shrinking revenues, operating losses, and a steep decline in cash flow generation.
Income Statement
20Very NegativeBalance Sheet
88Very PositiveCash Flow
35Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.49B | 2.61B | 2.80B | 2.92B | 2.78B | 3.42B |
| Gross Profit | 476.60M | 599.40M | 2.72B | 1.17B | 1.14B | 1.92B |
| EBITDA | -238.80M | -293.70M | -65.90M | 389.40M | 240.10M | 1.08B |
| Net Income | -107.00M | -109.30M | 50.40M | 242.40M | 64.00M | 831.90M |
Balance Sheet | ||||||
| Total Assets | 0 | 5.47B | 5.25B | 5.13B | 4.93B | 7.16B |
| Cash, Cash Equivalents and Short-Term Investments | 2.18B | 2.18B | 1.93B | 2.20B | 1.88B | 3.54B |
| Total Debt | 0 | 1.10M | 3.10M | 0 | 0 | 0 |
| Total Liabilities | -4.37B | 1.10B | 835.60M | 756.30M | 735.90M | 882.50M |
| Stockholders Equity | 4.37B | 4.37B | 4.41B | 4.37B | 4.20B | 6.28B |
Cash Flow | ||||||
| Free Cash Flow | -189.90M | 4.10M | -367.20M | 106.30M | 267.30M | 741.30M |
| Operating Cash Flow | -54.30M | 158.30M | -223.00M | 181.90M | 308.10M | 799.80M |
| Investing Cash Flow | -102.90M | -261.80M | 159.70M | 61.50M | 1.85B | 1.26B |
| Financing Cash Flow | 16.20M | 27.60M | -103.20M | 16.00M | -2.12B | -2.14B |
Quick Heal Technologies Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:QUICKHEAL, the sentiment is Positive. The current price of 154.85 is above the 20-day moving average (MA) of 141.23, above the 50-day MA of 143.93, and below the 200-day MA of 166.57, indicating a neutral trend. The MACD of -0.84 indicates Negative momentum. The RSI at 60.49 is Neutral, neither overbought nor oversold. The STOCH value of 34.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:QUICKHEAL.
Quick Heal Technologies Ltd. Peers Comparison
Overall Rating
IN:KELLTONTEC68Neutral
IN:EMUDHRA65Neutral
IN:KSOLVES64Neutral
IN:SUBEXLTD51Neutral
IN:QUICKHEAL47Neutral
IN:SECURKLOUD37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 68Neutral | INR 5.79B | 6.53 | ― | ― | 9.34% | 2.71% | |
| 65Neutral | INR 28.25B | 24.11 | ― | 0.37% | 29.74% | 25.01% | |
| 64Neutral | INR 4.75B | 13.18 | ― | 4.99% | 10.91% | 15.87% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 51Neutral | INR 9.19B | 30.24 | ― | ― | 2.91% | ― | |
| 47Neutral | INR 8.40B | -83.94 | ― | ― | -6.64% | -137.20% | |
| 37Underperform | INR 512.52M | -2.59 | ― | ― | -50.11% | 87.17% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:QUICKHEAL | Quick Heal Technologies Ltd. | 154.85 | -170.45 | -52.40% | |
| IN:EMUDHRA | eMudhra Limited | 341.10 | -297.80 | -46.61% | |
| IN:KELLTONTEC | Kellton Tech Solutions Ltd. | 10.90 | -10.65 | -49.42% | |
| IN:KSOLVES | Ksolves India Ltd | 200.10 | -107.52 | -34.95% | |
| IN:SECURKLOUD | SecureKloud Technologies Limited | 15.34 | -4.96 | -24.43% | |
| IN:SUBEXLTD | Subex Limited | 16.36 | 3.31 | 25.36% |
Quick Heal Technologies Ltd. Corporate Events
Quick Heal Technologies Announces Resignation of Company Secretary
Quick Heal Technologies Ltd. has announced that its Company Secretary and Key Managerial Personnel, Mr. Sarang Deshpande, has resigned from his position for personal reasons, with his last working day set on or before October 27, 2026. The company ha...
Exchange Seeks Clarity as Quick Heal’s Trading Volume Surges
The stock of Quick Heal Technologies Ltd. has seen a significant increase in trading volume, prompting the exchange to seek updated, relevant information from the company. The move aims to safeguard investor interests by ensuring transparency around...
Quick Heal Names Amit Chaudhary Vice President of Product Management
Quick Heal Technologies Ltd. has appointed Amit Chaudhary as Vice President, Product Management and a member of its senior management team, effective September 1, 2026. Chaudhary brings over 26 years of experience in IT and telecom, with deep experti...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 31, 2026